Abingworth LLP 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,183,716 7.900% | 14,998 (+0.36%) | Filing |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,168,718 8.200% | 4,168,718 (New Position) | Filing |